RA Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.04M | Buy |
2,661,331
+1,661,331
| +166% | +$3.77M | 0.1% | 53 |
|
|
2025
Q1 | $636K | Buy |
+1,000,000
| New | +$636K | 0.01% | 84 |
|
|
2021
Q4 | – | Sell |
-3,500,000
| Closed | -$17.8M | – | 99 |
|
|
2021
Q3 | $17.8M | Hold |
3,500,000
| – | – | 0.25% | 64 |
|
|
2021
Q2 | $22.2M | Hold |
3,500,000
| – | – | 0.36% | 59 |
|
|
2021
Q1 | $27.1M | Buy |
+3,500,000
| New | +$27.1M | 0.41% | 51 |
|